Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemias
- 1 August 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (8), 919-923
- https://doi.org/10.1016/0277-5379(85)90108-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adultsBlood, 1982
- EFFECTS OF ACLACINOMYCIN ON CELL-SURVIVAL AND CELL-CYCLE PROGRESSION OF CULTURED MAMMALIAN-CELLS1981
- A phase II study of aclacinomycin A in acute leukemia in adultsCancer Treatment Reviews, 1980
- CELLULAR ACCUMULATION AND DISPOSITION OF ACLACINOMYCIN-A1979
- STRUCTURE-ACTIVITY-RELATIONSHIPS OF ANTHRACYCLINES RELATIVE TO EFFECTS ON MACROMOLECULAR SYNTHESES1978
- Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcomaCancer Chemotherapy and Pharmacology, 1978
- Progress in the Treatment of Adults With Acute LeukemiaArchives of Internal Medicine, 1976
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- RANDOMIZED CLINICAL COMPARISON OF DAUNORUBICIN (NSC-82151) ALONE WITH A COMBINATION OF DAUNORUBICIN, CYTOSINE-ARABINOSIDE (NSC-63878), 6-THIOGUANINE (NSC-752), AND PYRIMETHAMINE (NSC-3061) FOR TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA1976
- Arabinosyl Cytosine: A Useful Agent in the Treatment of Acute Leukemia in AdultsBlood, 1968